全文获取类型
收费全文 | 1901篇 |
免费 | 132篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 66篇 |
妇产科学 | 10篇 |
基础医学 | 154篇 |
口腔科学 | 78篇 |
临床医学 | 166篇 |
内科学 | 373篇 |
皮肤病学 | 24篇 |
神经病学 | 198篇 |
特种医学 | 302篇 |
外科学 | 215篇 |
综合类 | 21篇 |
一般理论 | 14篇 |
预防医学 | 191篇 |
眼科学 | 44篇 |
药学 | 103篇 |
肿瘤学 | 95篇 |
出版年
2021年 | 15篇 |
2019年 | 13篇 |
2018年 | 33篇 |
2017年 | 14篇 |
2016年 | 12篇 |
2015年 | 15篇 |
2014年 | 25篇 |
2013年 | 47篇 |
2012年 | 55篇 |
2011年 | 58篇 |
2010年 | 55篇 |
2009年 | 41篇 |
2008年 | 60篇 |
2007年 | 74篇 |
2006年 | 64篇 |
2005年 | 75篇 |
2004年 | 65篇 |
2003年 | 37篇 |
2002年 | 36篇 |
2001年 | 65篇 |
2000年 | 67篇 |
1999年 | 72篇 |
1998年 | 75篇 |
1997年 | 68篇 |
1996年 | 44篇 |
1995年 | 48篇 |
1994年 | 38篇 |
1993年 | 32篇 |
1992年 | 45篇 |
1991年 | 48篇 |
1990年 | 39篇 |
1989年 | 53篇 |
1988年 | 53篇 |
1987年 | 46篇 |
1986年 | 58篇 |
1985年 | 51篇 |
1984年 | 35篇 |
1983年 | 32篇 |
1982年 | 19篇 |
1981年 | 18篇 |
1980年 | 28篇 |
1979年 | 35篇 |
1978年 | 17篇 |
1977年 | 25篇 |
1976年 | 33篇 |
1975年 | 15篇 |
1973年 | 16篇 |
1972年 | 14篇 |
1971年 | 12篇 |
1968年 | 12篇 |
排序方式: 共有2060条查询结果,搜索用时 156 毫秒
991.
呼吸道感染患者肺炎衣原体感染的研究 总被引:8,自引:0,他引:8
呼吸道感染患者肺炎衣原体感染的研究施毅夏锡荣冯根宝胡兰萍康晓明肺炎衣原体是80年代后期新发现的呼吸道感染病原体[1]。我们采用微量免疫荧光试验(micro-IF)对呼吸道感染住院患者肺炎衣原体感染进行了研究。对象与方法(1)病例选择:1995年1~1... 相似文献
992.
Wethers DL; Ramirez GM; Koshy M; Steinberg MH; Phillips G Jr; Siegel RS; Eckman JR; Prchal JT 《Blood》1994,84(6):1775-1779
Leg ulcers are a chronic manifestation of sickle-cell disease (SCD) and are often painful, disabling, and difficult to treat. RGD peptide matrix treatment is a novel therapy designed to provide a topical synthetic extracellular matrix that can act as a temporary substitute for the damaged natural matrix at the ulcer site. In this randomized, placebo-controlled, double-blind, prospective, multicenter investigation, SCD patients with full-thickness leg ulcers were treated with standard therapy plus RGD peptide matrix or saline placebo once weekly for up to 10 weeks. Healing in patients with chronic ulcers (2 months or greater in duration) was significantly accelerated (P = .0085) in RGD peptide matrix recipients compared with the placebo group. In these chronic ulcer cases, the average percent ulcer closure (decrease in ulcer surface area) in the RGD peptide matrix group (54.4% +/- 8.9%) exceeded that in the placebo group (19.0% +/- 24.3%) nearly threefold by study endpoint. Furthermore, RGD peptide matrix was equally effective in promoting healing of long persistent ulcers and ulcers of shorter duration. In contrast, standard therapy plus placebo was significantly less effective (P = .001) in promoting healing for ulcers of progressively greater duration. The results of this study provide preliminary evidence that RGD peptide matrix treatment may significantly accelerate healing of chronic sickle-cell leg ulcers. 相似文献
993.
Lyman SD; Seaberg M; Hanna R; Zappone J; Brasel K; Abkowitz JL; Prchal JT; Schultz JC; Shahidi NT 《Blood》1995,86(11):4091-4096
The flt3 ligand is a growth factor that stimulates the proliferation of hematopoietic progenitor and stem cells. We established a sensitive enzyme-linked immunosorbent assay (ELISA) to measure the concentration of flt3 ligand in plasma or serum from normal individuals, as well as in patients with hematopoietic disorders. Concentrations of flt3 ligand in plasma or serum from normal individuals were quite low: only 12% (7 of 60) of normal individuals had flt3 ligand levels above 100 pg/mL (the limit of detection). In contrast, 86% (19 of 22) of samples from patients with Fanconi anemia and 100% (eight of eight) of samples from patients with acquired aplastic anemia had plasma or serum levels above 100 pg/mL. Mean plasma or serum concentrations (calculated by assigning a value of 0 pg/mL to any sample reading below the level of detection) were as follows: normal volunteers, 14 pg/mL; patients with Fanconi anemia, 1,331 pg/mL; and patients with acquired aplastic anemia, 460 pg/mL. Concentrations of flt3 ligand in blood are, therefore, specifically elevated to a level that may be physiologically relevant in hematopoietic disorders with a suspected stem cell component. The elevated flt3 ligand concentrations in these individuals may be part of a compensatory hematopoietic response to boost the level of progenitor cells. 相似文献
994.
The frequency of three serologically defined HLA-D region antigens--DR, MB, and MT--was determined in a group of 74 children with non-T, non-B acute lymphocytic leukemia (ALL). Statistically, there were no significant differences in the frequency of any antigen in these ALL patients as compared with a panel of 85 normal controls. However, significant differences in HLA-DR frequencies were observed between patients who relapsed or who remained disease-free during a 30-mo period of chemotherapy. An increased incidence of relapse was associated with DR5, while disease-free remission during chemotherapy was associated with DR7. Life table analysis also demonstrated that DR5 was significantly associated with a decrease in disease-free survival in these patients. These data suggest that HLA-associated genetic factors may influence the responses of ALL patients to chemotherapy. 相似文献
995.
Clonality in juvenile chronic myelogenous leukemia 总被引:2,自引:2,他引:2
Busque L; Gilliland DG; Prchal JT; Sieff CA; Weinstein HJ; Sokol JM; Belickova M; Wayne AS; Zuckerman KS; Sokol L 《Blood》1995,85(1):21-30
Juvenile chronic myelogenous leukemia (JCML) is a myeloproliferative disease in which morbidity and mortality are primarily caused by nonhematopoietic organ failure from myelomonocytic infiltration or by failure of the normal bone marrow. Morphologic evidence of maturation arrest, karyotypic abnormalities, and progression to blast crisis are infrequent events. Viral infections and other reactive processes can initially mimic the clinical course of JCML, creating diagnostic problems. Because of the rarity of JCML and technical limitations, formal clonality studies have not been reported previously. Nine female JCML patients were identified by clinical criteria, characteristic 'spontaneous' in vitro cell growth, and negative cultures and titers for various viral agents. Peripheral blood and bone marrow samples were obtained at the time of diagnosis for cell separation and RNA and DNA isolation. To assess clonality, X-chromosome inactivation patterns were evaluated using three different, recently developed polymerase chain reaction-based clonality assays. All nine female JCML patients showed evidence for monoclonal origin of mononuclear cells at the time of diagnosis. Cell separation studies further traced the monoclonal origin back to at least the most primitive myeloid progenitor cell. Reversion to a polyclonal state was demonstrated after bone marrow transplant and also in one patient following treatment with 13-cis retinoic acid. This demonstration of clonality in JCML delineates it from the reactive processes and provides a basis for molecular genetic strategies to identify causally associated mutations. 相似文献
996.
Deactivation of the renin-angiotensin-aldosterone system (RAAS) is clearly beneficial in patients with recent myocardial infarction
and chronic heart failure. Most of the experience with deactivation of the RAAS has been collected in placebo-controlled randomized
trials of angiotensinconverting enzyme inhibition (ACEI). The hypothesis that angiotensin receptor blockade may be a better
approach to deactivate the RAAS has not survived the test of time. Despite the extensive experience with ACEI and aldosterone
receptor blockade in patients with recent myocardial infarction and chronic heart failure, several issues remain unanswered.
These are addressed in this review. 相似文献
997.
Design of Axial Blood Pumps for Patients With Dysfunctional Fontan Physiology: Computational Studies and Performance Testing
下载免费PDF全文
![点击此处可从《Artificial organs》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Dhyaa H. Kafagy Thomas W. Dwyer Kelli L. McKenna Jean P. Mulles Steven G. Chopski William B. Moskowitz Amy L. Throckmorton 《Artificial organs》2015,39(1):34-42
Limited treatment options for patients having dysfunctional single ventricle physiology motivate the necessity for alternative therapeutic options. To address this unmet need, we are developing a collapsible axial flow blood pump. This study investigated the impact of geometric simplicity to facilitate percutaneous placement and maintain optimal performance. Three new pump designs were numerically evaluated. A transient simulation explored the impact of respiration on blood flow conditions over the entire respiratory cycle. Prototype testing of the top performing pump design was completed. The top performing Rec design generated the highest pressure rise range of 2–38 mm Hg for flow rates of 1–4 L/min at 4000–7000 RPM, exceeding the performance of the other two configurations by more than 26%. The blood damage indices for the new pump designs were determined to be below 0.5% and predicted hemolysis levels remained low at less than 7 × 10?5 g/100 L. Prototype testing of the Rec design confirmed numerical predictions to within an average of approximately 22%. These findings demonstrate that the pumps are reasonably versatile in operational ability, meet pressure‐flow requirements to support Fontan patients, and are expected to have low levels of blood trauma. 相似文献
998.
S Gourtsoyianni S Hwang DM Panicek J Zheng C Moskowitz H Scher M Morris H Hricak 《The British journal of radiology》2012,85(1017):1243-1249
Objectives The objective of this study was to determine whether, in patients with prostate cancer (PCa) bone metastases receiving chemotherapy, early post-treatment changes on CT are reproducible and associated with clinical outcomes. Methods Blinded to outcomes, two radiologists with 1 year and 5 years of experience independently reviewed CTs obtained before and 3 months after chemotherapy initiation in 38 patients with bone metastases from castration-resistant PCa, recording the size, matrix and attenuation of ≤5 lesions; presence of new lesions, extraosseous components, periosteal reactions and cortical thickening; and overall CT assessment (improved, no change or worse). Kappa statistics were used to assess inter-reader agreement; the Kruskal-Wallis test and Cox regression model were used to evaluate associations. Results Inter-reader agreement was low/fair for size change (concordance correlation coefficient=0.013), overall assessment and extraosseous involvement (κ=0.3), moderate for periosteal reaction and cortical thickening (κ=0.4-0.5), and substantial for CT attenuation (κ=0.7). Most metastases were blastic (Reader 1, 58%; Reader 2, 67%) or mixed lytic-blastic (Reader 1, 42%; Reader 2, 34%). No individual CT features correlated with survival. Readers 1 and 2 called the disease improved in 26% and 5% of patients, unchanged in 11% and 21%, and worse in 63% and 74%, respectively, with 64% interreader agreement. Overall CT assessment did not correlate with percentage change in prostate-specific antigen level. For the more experienced reader (Reader 2), patients with improved or unchanged disease had significantly longer median survival (p=0.036). Conclusions In PCa bone metastases, interreader agreement is low in overall CT post-treatment assessment and varies widely for individual CT features. Improved or stable disease identified by an experienced reader is statistically associated with longer survival. 相似文献
999.
HA Vargas J Chaim RA Lefkowitz Y Lakhman J Zheng CS Moskowitz MJ Sohn LH Schwartz P Russo O Akin 《Radiology》2012,264(3):779-788
Purpose: To investigate the use of quantitative multiphasic contrast material-enhanced magnetic resonance (MR) imaging in differentiating between common benign and malignant histologic subtypes of renal cortical tumors. Materials and Methods: The institutional review board waived informed consent and approved this retrospective HIPAA-compliant study of 138 patients who underwent preoperative contrast-enhanced MR imaging during the period of January 2004-December 2008. At surgery, 152 renal tumors were identified (77 clear cell, 22 papillary, 18 chromophobe, and 10 unclassified carcinomas; 16 oncocytomas; nine angiomyolipomas). Three readers independently identified and measured the most-enhanced area in each tumor and placed corresponding regions of interest in similar positions on images from the precontrast, corticomedullary, nephrographic, and excretory phases. The percentage change in signal intensity (%SI change) between precontrast imaging and each postcontrast phase was calculated. Interreader agreement was evaluated by using the overall concordance correlation coefficient (OCC). A linear mixed-effects model was used to estimate and compare the trajectories of the means of log %SI change across all phases between the six histologic subtypes. Results: Interreader agreement was substantial to almost perfect (OCC, 0.77-0.88). The %SI change differed significantly between clear cell carcinomas and papillary and chromophobe carcinomas in all phases of enhancement (P < .0001-.0120). In addition, %SI change was significantly higher in angiomyolipomas than in clear cell carcinomas, but only in the corticomedullary phase (P = .0231). Enhancement did not differ significantly between clear cell carcinoma and oncocytoma in any phase (P = .2081-.6000). Conclusion: Quantitative multiphase contrast-enhanced MR imaging offers a widely available, reproducible method to characterize several histologic subtypes of renal cortical tumors, although it does not aid differentiation between clear cell carcinomas and oncocytomas. ? RSNA, 2012. 相似文献
1000.